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The aims of any research effort in the field 
of physiology are to promote human health, 
to improve quality of life of individuals in 
addition to making new scientific discover-
ies, which may eventually open new fields 
of investigation. Novel research in physiol-
ogy now provides new opportunities from 
translational research, e.g., from technology, 
engineering, behavioral sciences, biology, 
biochemistry, physics, as well as from basic 
research in genetics, genomics, and molec-
ular research to epidemiology, prevention, 
and bedside clinical research. The combina-
tion of various scientific fields serves as a 
new approach to promote science, which 
has now been recognized also by the major 
funding organizations throughout the 
world (Berro et al., 2011; Bolon et al., 2011).
The main challenges in for clinical and 
translational physiology are to combine these 
new scientific approaches. There are few 
high-level international journals that directly 
combine research in these areas, i.e., basic 
physiology and its related research topics to 
clinical research and clinical practice. Most 
of the currently available physiology journals 
focus exclusively on the particular aspects of 
a given field of physiology usual without any 
emphasis on the clinical application of the 
results of these studies. On the other hand, 
most of the general medical journals and 
specialized clinical journals focus only on 
specific and relevant clinical problems in 
their own fields with little no emphasis on 
the underlying physiological abnormalities 
that give rise to disease. Therefore, Frontiers 
in Clinical and Translational Physiology will 
open new opportunities for those scientists 
who perform their research in physiology or 
translational areas of research with direct or 
indirect clinical applications.
The number of studies covered by this 
Journal are limitless. However, a few very 
general examples help illustrate the types of 
studies and interactions fall under the head-
ing Frontiers in Clinical and Translational 
Physiology. Studies that combine research on 
autonomic neurosciences to clinical applica-
tions, or that link genome-wide association 
studies to risk stratification at the level of 
well-defined patient groups or general popu-
lation samples. Other examples may include 
the combination of research on medical tech-
nology to clinical applications, new methods 
to be used in clinical practice, and to promote 
basic science discoveries into diagnostics 
and treatment as well clinical discoveries to 
clinical practice. Translational research also 
encompasses the effective movement of new 
knowledge to diagnosis and treatment of dis-
eases. There have been many roadblocks to 
successful movement of these discoveries. 
One of these has been the lack of publica-
tion forums for translational research.
The aim of the journal is open a new 
platform for scientists from many fields of 
physiology, such as cardiovascular, gastroin-
testinal, liver, endocrinology, metabolism, 
renal, bone and muscle, cancer, psychiatric, 
cell, preventive, rehabilitation, and exercise 
physiology. The aim of translational part 
of the journal is to attract scientists from 
other fields of research, e.g., technology, 
engineering, behavioral sciences, psychol-
ogy, biochemistry, physics, etc., who work in 
collaboration with clinical investigators. In 
addition, our aim is to attract clinical scien-
tists who use methods or study designs based 
on physiology or translational sciences.
Closing gaps between the clinical, physi-
ological, and translational research will be 
the main current challenge as well as the 
challenge for future research in attempts to 
promote science and human health. With 
the launch of Frontiers in Clinical and 
Translational Physiology, we provide new 
tools to meet these challenges. Open access, 
tiered publication in combination with 
interaction with the reviewers set the stage 
for optimal exchange of scientific infor-
mation in this field. Many types of manu-
scripts are welcomed, including hypothesis 
generating articles, opinion articles, and 
mini-reviews in addition to more general 
original articles.
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